Category: Substance abuse treatment

While the brand-name Subutex was officially discontinued in 2011, manufacturers continue to produce generic **buprenorphine without naloxone** for specific medical needs. The landscape of addiction medicine has evolved significantly, with various formulations now available to address different patient requirements, from induction to long-term care.

According to the National Institute on Drug Abuse, medications for opioid use disorder, like the one associated with the N8 pill imprint, have been shown to reduce overdose deaths by 50%. The N8 pill typically refers to a sublingual medication containing buprenorphine and naloxone, a key component of medication-assisted treatment for opioid dependence.

Methadone has been used for decades to treat opioid addiction and chronic pain. A specific formulation known as Metadol-D is available primarily in Canada, where it serves as a key option for opioid agonist treatment (OAT) in supervised medical settings.